Earnings Reaction: Progressive shares fell 1.3% in pre-market trading after Q1 results, sparking cautious chatter on social media about the insurer's performance. Investors dissected the numbers, noting a blend of solid metrics and market headwinds. The dip tempered enthusiasm despite underlying strengths.
AI Edge Highlighted: Buoyed by AI's potential, some highlighted Progressive as a prime beneficiary through sharper underwriting and fraud controls. At around 10x GAAP net income, the stock drew praise for its value in a data-driven era. Debates touched on self-driving risks but affirmed long-term advantages.
Analyst and Market Views: BMO lifted its price target to $221 from $208 with a Market Perform nod, signaling steady confidence. Rising premiums in key markets fueled talk of tailwinds for top-tier players like Progressive. Sentiment remains watchful amid broader insurance dynamics.
Note: This discussion summary was generated from an AI condensation of post data.
Progressive Insider Trading Activity
Progressive insiders have traded $PGR stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $PGR stock by insiders over the last 6 months:
- JOHN P SAUERLAND (VP and Chief Financial Officer) sold 5,000 shares for an estimated $1,142,400
- JONATHAN S. BAUER (Chief Investment Officer) has made 0 purchases and 2 sales selling 5,371 shares for an estimated $1,094,618.
- STEVEN BROZ (Chief Information Officer) has made 0 purchases and 3 sales selling 4,034 shares for an estimated $905,081.
- KAREN BAILO (Commercial Lines President) sold 3,517 shares for an estimated $745,604
- ANDREW J QUIGG (Chief Strategy Officer) sold 1,649 shares for an estimated $336,973
- DEVIN C JOHNSON sold 980 shares for an estimated $199,038
- MARIBEL PUMAREJO (Chief Marketing Oficer) sold 738 shares for an estimated $150,137
- CARL G JOYCE (Chief Accounting Officer) has made 0 purchases and 2 sales selling 411 shares for an estimated $85,645.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Progressive Congressional Stock Trading
Members of Congress have traded $PGR stock 10 times in the past 6 months. Of those trades, 6 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $PGR stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 4 purchases worth up to $60,000 on 02/10, 01/16, 11/03 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 10/27.
- REPRESENTATIVE BYRON DONALDS purchased up to $15,000 on 10/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Progressive Hedge Fund Activity
We have seen 815 institutional investors add shares of Progressive stock to their portfolio, and 895 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 17,745,348 shares (-75.7%) from their portfolio in Q4 2025, for an estimated $4,040,970,646
- FMR LLC removed 5,299,126 shares (-43.4%) from their portfolio in Q4 2025, for an estimated $1,206,716,972
- WELLINGTON MANAGEMENT GROUP LLP added 4,197,212 shares (+181.8%) to their portfolio in Q4 2025, for an estimated $955,789,116
- BLACKROCK, INC. added 3,391,410 shares (+7.0%) to their portfolio in Q4 2025, for an estimated $772,291,885
- JPMORGAN CHASE & CO removed 2,827,619 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $643,905,398
- EGERTON CAPITAL (UK) LLP removed 2,588,638 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $589,484,645
- NUVEEN, LLC removed 1,688,787 shares (-33.4%) from their portfolio in Q4 2025, for an estimated $384,570,575
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Progressive Analyst Ratings
Wall Street analysts have issued reports on $PGR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 01/29/2026
- Barclays issued a "Overweight" rating on 01/08/2026
- B of A Securities issued a "Buy" rating on 11/19/2025
To track analyst ratings and price targets for Progressive, check out Quiver Quantitative's $PGR forecast page.
Progressive Price Targets
Multiple analysts have issued price targets for $PGR recently. We have seen 13 analysts offer price targets for $PGR in the last 6 months, with a median target of $223.0.
Here are some recent targets:
- Elyse Greenspan from Wells Fargo set a target price of $218.0 on 04/16/2026
- Michael Zaremski from BMO Capital set a target price of $221.0 on 04/16/2026
- Joshua Shanker from B of A Securities set a target price of $312.0 on 04/16/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $210.0 on 04/07/2026
- Bob Huang from Morgan Stanley set a target price of $190.0 on 03/31/2026
- Andrew Andersen from Jefferies set a target price of $215.0 on 03/24/2026
- Brian Meredith from UBS set a target price of $220.0 on 03/23/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
